Additive anti-atherogenic effect of thromboxane receptor antagonism with 12/15lipoxygenase gene disruption in apolipoprotein E-deficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/18206890

Download in:

View as

General Info

PMID
18206890